tiprankstipranks
Trending News
More News >
Ascletis Pharma, Inc. (HK:1672)
:1672
Hong Kong Market

Ascletis Pharma, Inc. (1672) Technical Analysis

Compare
8 Followers

Summary of all the Indicators

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Ascletis Pharma, Inc.’s (1672) Moving Averages Convergence Divergence (MACD) indicator is 1.05, suggesting Ascletis Pharma, Inc. is a Sell.
Ascletis Pharma, Inc.’s (1672) 20-Day exponential moving average is 15.21, while Ascletis Pharma, Inc.’s (1672) share price is HK$17.66, making it a Buy.
Ascletis Pharma, Inc.’s (1672) 50-Day exponential moving average is 14.01, while Ascletis Pharma, Inc.’s (1672) share price is HK$17.66, making it a Buy.

Ascletis Pharma, Inc. (1672) Pivot Points

Feb 23, 2026, 11:12 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
15.00
15.40
16.00
16.40
17.00
17.40
18.00
Fibonacci
15.40
15.78
16.02
16.40
16.78
17.02
17.40
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ascletis Pharma, Inc. (1672) Moving Averages

Feb 23, 2026, 11:12 PM
Period
Simple
Exponential
MA5
16.86Buy
16.83Buy
MA10
16.06Buy
16.14Buy
MA20
14.78Buy
15.21Buy
MA50
13.78Buy
14.01Buy
MA100
12.50Buy
13.01Buy
MA200
11.39Buy
11.30Buy
Ascletis Pharma, Inc.’s (1672) 10-Day exponential moving average is 16.14, while Ascletis Pharma, Inc.’s (1672) share price is HK$17.66, making it a Buy.
Ascletis Pharma, Inc.’s (1672) 100-Day exponential moving average is 13.01, while Ascletis Pharma, Inc.’s (1672) share price is HK$17.66, making it a Buy.
Ascletis Pharma, Inc.’s (1672) stock price is HK$17.66 and Ascletis Pharma, Inc.’s (1672) 50-day simple moving average is 13.78, creating a Buy signal.
Ascletis Pharma, Inc.’s (1672) stock price is HK$17.66 and Ascletis Pharma, Inc.’s (1672) 100-day simple moving average is 12.50, creating a Buy signal.
Ascletis Pharma, Inc.’s (1672) stock price is HK$17.66 and Ascletis Pharma, Inc.’s (1672) 200-day simple moving average is 11.39, creating a Buy signal.

Ascletis Pharma, Inc. (1672) Technical Indicators

Feb 23, 2026, 11:12 PM
Name
Value
Implied Action
RSI (14)
70.17
Sell
STOCH (9,6)
69.63
Neutral
STOCHRSI (14)
71.65
Neutral
MACD (12,26)
1.05
Sell
ADX (14)
36.27
Neutral
Williams %R
-15.91
Sell
CCI (14)
123.51
Sell
ATR (14)
1.11
-
Ultimate Oscillator
60.30
Neutral
ROC
33.28
Buy
Ascletis Pharma, Inc.’s (1672) Relative Strength Index (RSI) is 70.17, creating a Sell signal.
Ascletis Pharma, Inc.’s (1672) Trend Strength Indicator (ADX) is 36.27, creating a Neutral signal.
Ascletis Pharma, Inc.’s (1672) Commodity Channel Index (CCI) is 123.51, creating a Sell signal.
Ascletis Pharma, Inc.’s (1672) Price Rate of Change (ROC) is 33.28, creating a Buy signal.

FAQ

Is 1672 a Buy, Hold, or Sell?
Based on 1672’s technical indicators, 1672 is a Buy.
    What is 1672’s RSI (14)?
    1672’s RSI (14) is 70.17, which suggests 1672 is a Sell.
      What is 1672’s MACD?
      1672’s MACD is 1.05, which suggests 1672 is a Sell.
        What is 1672’s 5-day moving average?
        1672’s 5-day moving average is 16.86, which suggests 1672 is a Buy.
          What is 1672’s 20-day moving average?
          1672 20-day moving average is 14.78, which suggests 1672 is a Buy.
            What is 1672’s 50-day moving average?
            1672’s 50-day moving average is 13.78, which suggests 1672 is a Buy.
              What is 1672’s 200-day moving average?
              1672’s 200-day moving average is 11.39, which suggests 1672 is a Buy.
                What is 1672’s Williams % R (14)?
                1672’s Williams % R (14) is -15.91, which suggests 1672 is a Sell.
                  What is 1672’s CCI (14)?
                  1672’s CCI (14) is 123.51, which suggests 1672 is a Sell.
                    What is the share price of Ascletis Pharma, Inc.?